Does Adding Posterior Block to SFIB Increase the Quality of Analgesia in Hip Fractures?

January 5, 2026 updated by: Samsun University

Does the Addition of a Deep Posterior Gluteal Compartment Block to Suprainguinal Fascia Iliaca Block Improve Analgesia in Hip Fracture Surgery? A Randomized Controlled Trial

The researchers aimed to compare the effects of adding a Deep Posterior Gluteal Compartment Block to a Suprainguinal Fascia Iliaca Compartment Block (SFICB) versus SFICB alone on pain, analgesic consumption, and positioning pain for neuraxial anesthesia.

Study Overview

Detailed Description

Adding Deep Posterior Gluteal Compartment Block to Suprainguinal Fascia Iliaca Block applied before neuraxial anesthesia in hip fracture surgeries can reduce the pain sensation originating from the posterior region of the hip joint. Thus, participants can experience less pain in the perioperative period, consume less analgesics and reduce complications related to these in the postoperative period. In addition, possible complications can be prevented with early mobilization of the participants. It was aimed to compare the effects of adding Deep Posterior Gluteal Compartment Block to Suprainguinal Fascia Iliaca Block with only Suprainguinal Fascia Iliaca Block on these results.

Study Type

Interventional

Enrollment (Actual)

68

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ilkadım
      • Samsun, Ilkadım, Turkey (Türkiye)
        • Samsun University, Samsun Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Volunteering to participate in the study
  • Patients between the ages of 18-90
  • ASA I, II, III
  • Patients whose surgery duration does not exceed 2 hours
  • Patients who will undergo surgery under spinal anesthesia

Exclusion Criteria:

  • Patients who do not want to participate in the study/do not give consent
  • Patients with a condition that prevents regional anesthesia
  • Patients with cognitive dysfunction who are unable to evaluate the NRS score and who cannot use PCA (Patient Controlled Analgesia Device)
  • History of hypersensitivity or allergy to local anesthetics
  • Patients with psychiatric disorders and those using psychiatric medications
  • Presence of hematological disease
  • Presence of oncological disease
  • Patients with serious major organ failure
  • Presence of multiple fractures
  • Patients with alcohol or drug addiction
  • Patients who have used analgesic drugs up to 12 hours before surgery
  • ASA IV-V patients
  • Morbidly obese patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group SFICB
Suprainguinal fascia iliaca plane block will be performed 30 minutes before hip surgery
Suprainguinal fascia iliaca compartment block will be performed under USG guidance before neuraxial anesthesia.
Active Comparator: Group Combined
Suprainguinal Fascia İliaca plane Block will be performed 30 minutes before hip surgery and Deep Posterior Gluteal Compartment Block will be performed 20 minutes before hip surgery
Suprainguinal fascia iliaca compartment block will be performed under USG guidance before neuraxial anesthesia.
Deep Posterior Gluteal Compartment Block will be performed under USG guidance before neuraxial anesthesia.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Opioid consumption
Time Frame: 24 hours
In the postoperative period, patients will be given opioids according to their pain density with a patient-controlled device, and the daily Morphine consumption in Patient Controlled Analgesia device will be collected and compared between groups.
24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of recovery 15 scale
Time Frame: 24 hours after surgery
Postoperative Quality of Recovery 15 in Turkish scale
24 hours after surgery
Perioperative pain intensity
Time Frame: 24 hours

Changes in the Numerical Rating Scale (NRS) will be recorded at rest and during movement. The participant's baseline NRS will be recorded, followed by measurements before and after neuraxial positioning and up to 24 hours post-surgery.

The NRS is a unidimensional measure of pain intensity in adults. It is a segmented numerical version of the Visual Analog Scale (VAS) where the participant selects a whole number (0-10) that best represents the intensity of their pain. The 11-point numerical scale ranges from '0' representing one end of the pain spectrum (e.g. 'no pain') to '10' representing the other end (e.g. 'worst imaginable pain').

24 hours
Quality of patient's position for neuraxial anesthesia
Time Frame: up to ten minutes
The position will be evaluated by anesthesiologist and characterized as "unsatisfactory", "satisfactory", "good" or "very good"
up to ten minutes
Quadriceps weakness
Time Frame: 24th hours
Quadriceps strength will be graded according to a 3-point scale: normal strength = 0 point (extension against resistance); paresis = 1 point (extension against gravity but not against resistance); and paralysis = 2 points (no extension).
24th hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Hatice Selcuk Kusderci, Samsun University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 24, 2025

Primary Completion (Actual)

December 15, 2025

Study Completion (Actual)

December 31, 2025

Study Registration Dates

First Submitted

December 11, 2024

First Submitted That Met QC Criteria

February 17, 2025

First Posted (Actual)

February 21, 2025

Study Record Updates

Last Update Posted (Actual)

January 6, 2026

Last Update Submitted That Met QC Criteria

January 5, 2026

Last Verified

February 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Surgery

Clinical Trials on Suprainguinal fascia iliaca compartment block

Subscribe